Clinical Trial Update: Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD). [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the pharmacokinetics, safety, tolerability, and preliminary efficacy of 9MW1911 in adults with moderate-to-severe chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• 9MW1911

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING